Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
TELO: Telomir Pharmaceuticals, Inc. Common Stock Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
TELO
The Story
TELO
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-181.8%
Financially safe
Stretched
Debt / equity
0.04×
Interest coverage
-1763.2×
Current ratio
7.00×
Telomir Pharmaceuticals, Inc. Common Stock
TELO
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Telomir Pharmaceuticals, Inc. Common Stock
TELO
NASDAQ
·
USD
·
Closed
$1.21
−3.20%
$1.21
−$0.04 (3.20%)
52W Range
27th
pctl
Volume
0.38×
avg
Mkt Cap
41.60M
USD
P/E
-4.1
TTM
Div Yield
–
ann
52W Range
27th
pctl
Volume
0.38×
avg
Market Cap
41.60M
USD
P/E Ratio
-4.1
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings